high quality Lipstatin CAS NO.96829-59-3
- FOB Price: USD: 1.00-1.00 /Kilogram Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,T/T,
- Available Specifications:
Best Quality(1-10)Kilogram
- Product Details
Keywords
- Lipstatin
- high purity Lipstatin
- factory supply Lipstatin
Quick Details
- ProName: high quality Lipstatin
- CasNo: 96829-59-3
- Molecular Formula: C29H49NO5
- Appearance: white to slightly beige crystalline po...
- Application: Pharmaceutical intermediates
- DeliveryTime: in stock
- PackAge: as you requested
- Port: China main port
- ProductionCapacity: 10 Gram/Day
- Purity: 99%
- Storage: Room temperature
- Transportation: by sea
- LimitNum: 1 Kilogram
- Transportation: by courier
Superiority
Our company was built in 2009 with an ISO certificate.In the past 5 years, we have grown up as a famous fine chemicals supplier in China and we had established stable business relationships with Samsung,LG,Merck,Thermo Fisher Scientific and so on.Our main business covers the fields below:
1.Noble Metal Catalysts (Pt.Pd...)
2.Organic Phosphine Ligands (Tert-butyl-phosphine.Cyclohexyl-phosphine...)
3.OLED intermediates (Fluorene,Carbazole,Boric acid...)
4.Customs Synthesis
Our advantage:
1. Higest quality and good package
2.Fast delivery
3.Better payment term
4.Fast response to customer within 6 hours
5.Good business credit in Europe ,US ,Japan ,Korea
Anyway ,if you need any chemicals from China ,Henan Tianfu can help you
Details
CAS: | 96829-59-3 |
MF: | C29H49NO5 |
MW: | 491.708 |
EINECS: | |
Product Categories: | Chiral Reagents;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Amino Acids & Derivatives |
Mol File: | 96829-59-3.mol |
Lipstatin Chemical Properties |
density | 0.993 |
Safety Information |
Lipstatin Usage And Synthesis |
Uses | Lipstatin, a potent inhibitor of the pancreas lipase, is reported to be useful in the treatment and/or prevention of obesity and related diseases. |
Uses | Lipstatin is a potent irreversible inhibitor of pancreatic lipase, produced by Streptomyces toxytricini and first reported in 1987. In vivo, lipstatin acts to block the absorption of triglycerides while allowing fatty acid absorption. The tetrahydro analogue of lipstatin, orlistat, although less potent, was developed for the treatment of obesity. |